Kimberly V Amelsberg
Overview
Explore the profile of Kimberly V Amelsberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uribe-Herranz M, Beghi S, Ruella M, Parvathaneni K, Salaris S, Kostopoulos N, et al.
Mol Ther
. 2023 Jan;
31(3):686-700.
PMID: 36641624
Several studies have shown the influence of commensal microbes on T cell function, specifically in the setting of checkpoint immunotherapy for cancer. In this study, we investigated how vancomycin-induced gut...
2.
Smith M, Dai A, Ghilardi G, Amelsberg K, Devlin S, Pajarillo R, et al.
Nat Med
. 2022 Oct;
29(11):2954.
PMID: 36253610
No abstract available.
3.
Lee Y, Guruprasad P, Ghilardi G, Pajarillo R, Sauter C, Patel R, et al.
Cancer Discov
. 2022 Jul;
12(10):2372-2391.
PMID: 35904479
Significance: This study highlights the role of BCL-2 in resistance to CART immunotherapy for cancer and introduces a novel concept for combination therapies-the engineering of CART cells to make them...
4.
Smith M, Dai A, Ghilardi G, Amelsberg K, Devlin S, Pajarillo R, et al.
Nat Med
. 2022 Mar;
28(4):713-723.
PMID: 35288695
Anti-CD19 chimeric antigen receptor (CAR) T cell therapy has led to unprecedented responses in patients with high-risk hematologic malignancies. However, up to 60% of patients still experience disease relapse and...